Actinium Pharmaceuticals logo
Actinium Pharmaceuticals ATNM
$ 1.26 12.5%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Actinium Pharmaceuticals Balance Sheet 2011-2024 | ATNM

Annual Balance Sheet Actinium Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-76.1 M -106 M - -63.2 M -7.83 M -13.4 M -17.4 M -20.5 M -25.4 M -6.42 M -5.38 M -5.48 M 120 K

Long Term Debt

19 K 2.08 M 3 K - - - - - - - - - -

Long Term Debt Current

530 K 494 K 245 K 342 K 287 K - - - - - - - -

Total Non Current Liabilities

- - - - 682 K 13.4 K - - - - - - 58.2 K

Total Current Liabilities

8.49 M 10.6 M 6.84 M 4.77 M 5.34 M 6.06 M 4.67 M 4.52 M 4.61 M 9.49 M 7.33 M 4.64 M 26.3 K

Total Liabilities

45.1 M 47.7 M 6.84 M 5.08 M 6.03 M 6.08 M 4.67 M 4.52 M 4.61 M 9.49 M 7.33 M 4.64 M 84.5 K

Deferred Revenue

- - 1 M - - - - - - - - - -

Retained Earnings

-338 M -289 M -256 M - -209 M -187 M -163 M -137 M -112 M -91.2 M -66.5 M -55.7 M -260 K

Total Assets

81.4 M 114 M 80.4 M 66.4 M 11.7 M 14.9 M 18.3 M 22.5 M 26.6 M 7.57 M 5.77 M 5.79 M 150

Cash and Cash Equivalents

76.7 M 109 M 77.8 M 63.6 M 9.25 M 13.7 M 17.4 M 20.5 M 25.6 M 6.71 M 5.53 M 5.62 M 5.7 M

Book Value

36.4 M 66.5 M 73.5 M 61.3 M 5.64 M 8.81 M 13.7 M 18 M 22 M -1.92 M -1.56 M 1.15 M -84.3 K

Total Shareholders Equity

36.4 M 66.5 M 73.5 M 61.3 M 5.64 M 8.81 M 13.7 M 18 M 22 M -1.92 M -1.56 M 1.15 M 992 K

All numbers in USD currency

Quarterly Balance Sheet Actinium Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

12 K 14 K 17 K 19 K 1.69 M - - 2.08 M 1 K 2.34 M - 3 K - - - - - - - 900 K 100 K 300 K 200 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

43.9 M 46 M 44.5 M 45.1 M 45.4 M 46 M 44.8 M 47.7 M 45.6 M 43.6 M 5.72 M 6.84 M 4.19 M 3.96 M 4.36 M 5.08 M 5.08 M 5.08 M 5.08 M 6.03 M 6.03 M 6.03 M 6.03 M 6.08 M 6.08 M 6.08 M 6.08 M 4.67 M 4.67 M 4.67 M 4.67 M 4.52 M 4.52 M 4.52 M 4.52 M 4.61 M 4.61 M 4.61 M 4.61 M 9.49 M 9.49 M 9.49 M 9.49 M 7.33 M 7.33 M 7.33 M - 4.64 M 4.64 M 4.64 M 94.1 K 84.5 K 81.8 K 84.5 K 84.5 K

Deferred Revenue

- - - - - 100 K - - 100 K 200 K 100 K 900 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-369 M -358 M -346 M -338 M -328 M -315 M -300 M -289 M -278 M -269 M -261 M -256 M -248 M -241 M -236 M -231 M -231 M -231 M -231 M -209 M -209 M -209 M -209 M -187 M -187 M -187 M -187 M -163 M -163 M -163 M -163 M -137 M -137 M -137 M -137 M -112 M -112 M -112 M -112 M -91.2 M -91.2 M -91.2 M -91.2 M -66.5 M -66.5 M -66.5 M 56.4 M 55.7 M -279 K -276 K -269 K -260 K -257 K -260 K -260 K

Total Assets

82.1 M 89.9 M 88.4 M 81.4 M 88.9 M 99.1 M 102 M 114 M 117 M 122 M 74.6 M 80.4 M 84.5 M 84.5 M 75.1 M 66.4 M 66.4 M 66.4 M 66.4 M 11.7 M 11.7 M 11.7 M 11.7 M 14.9 M 14.9 M 14.9 M 14.9 M 18.3 M 18.3 M 18.3 M 18.3 M 22.5 M 22.5 M 22.5 M 22.5 M 26.6 M 26.6 M 26.6 M 26.6 M 7.57 M 7.57 M 7.57 M 7.57 M 5.77 M 5.77 M 5.77 M 5.77 M 5.79 M 5.79 M 5.79 M 5.79 M 6.2 M 150 150 150

Cash and Cash Equivalents

78.7 M 86 M 84.1 M 76.7 M 83.3 M 91.6 M 95.2 M 109 M 113 M 117 M 72.4 M 77.8 M 82.5 M 82.4 M 72.3 M 63.6 M 63.6 M 63.6 M 63.6 M 9.25 M 9.25 M 9.25 M 9.25 M 13.7 M 13.7 M 13.7 M 13.7 M 17.4 M 17.4 M 17.4 M 17.4 M 20.5 M 20.5 M 20.5 M 20.5 M 25.6 M 25.6 M 25.6 M 25.6 M 6.71 M 6.71 M 6.71 M 6.71 M 5.53 M 5.53 M 5.53 M 5.53 M 5.62 M 5.62 M 5.62 M 5.62 M 5.7 M 150 150 150

Book Value

38.2 M 43.8 M 43.9 M 36.4 M 43.6 M 53.1 M 57.2 M 66.5 M 71.3 M 78.2 M 68.8 M 73.5 M 80.3 M 80.5 M 70.7 M 61.3 M 61.3 M 61.3 M 61.3 M 5.64 M 5.64 M 5.64 M 5.64 M 8.81 M 8.81 M 8.81 M 8.81 M 13.7 M 13.7 M 13.7 M 13.7 M 18 M 18 M 18 M 18 M 22 M 22 M 22 M 22 M -1.92 M -1.92 M -1.92 M -1.92 M -1.56 M -1.56 M -1.56 M 5.77 M 1.15 M 1.15 M 1.15 M 5.69 M 6.12 M -81.7 K -84.3 K -84.3 K

Total Shareholders Equity

38.2 M 43.8 M 43.9 M 36.4 M 43.6 M 53.1 M 57.2 M 66.5 M 71.3 M 78.2 M 68.8 M 73.5 M 80.3 M 80.5 M 70.7 M 61.3 M 61.3 M 61.3 M 61.3 M 5.64 M 5.64 M 5.64 M 5.64 M 8.81 M 8.81 M 8.81 M 8.81 M 13.7 M 13.7 M 13.7 M 13.7 M 18 M 18 M 18 M 18 M 22 M 22 M 22 M 22 M -1.92 M -1.92 M -1.92 M -1.92 M -1.56 M -1.56 M -1.56 M -1.56 M 1.15 M 1.15 M 1.15 M 1.15 M 992 K -84.3 K -84.3 K -84.3 K

All numbers in USD currency